Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "hyperphosphatemic familial tumoral calcinosis" [DISEASE] OR NCT01003223 [ID-NUMBER] OR NCT00004358 [ID-NUMBER]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Phase II Study of Calcitonin for Tumoral Calcinosis
Condition: Calcinosis
Intervention: Drug: calcitonin
2 Completed Phosphate Kinetic Modeling
Conditions: End Stage Renal Disease;   Hyperphosphatemia
Intervention: Other: Computer algorithm management of hyperphosphatemia

Indicates status has not been verified in more than two years